Our specialty and biosimilar products

biosimilar products 1026X430.jpg

We are guided by a desire to enable people to have greater control over their health and live life to its fullest potential. A steadfast commitment to our patients runs to the heart of everything we do, and our high-quality products make a difference in the lives of thousands of Canadians, every day.
Should you have any questions about our products, please do not hesitate to contact us. Our Customer Care department can be reached at (416) 291-8888 ext. 5750 (during regular business hours) or ext. 5216 (after regular business hours).

Note: Canadian regulations limit the scope of information we are permitted to provide in relation to prescription drugs. Please consult with your healthcare professional for more detailed information on any of our products.

Specialty medicines

Aermony RespiClick™

Toggle Expand/ Collapse

Strength

55 mcg/actuation, 113 mcg/actuation and 232 mcg/actuation

DIN

02467895 (55 mcg/actuation); 02467909 (113 mcg/actuation); 02467917 (232 mcg/actuation)

To view the Aermony RespiClick™ (fluticasone propionate) product monograph, click here.

For more information on how to use Aermony RespiClickTM, please view the video below.

Strength

Solution for subcutaneous injection. 

225 mg/mL solution in a single-dose prefilled syringe 

225 mg/mL solution in a single-dose prefilled autoinjector 

Dosing

225 mg (1 subcutaneous injection) once a month – monthly dosing, or 

675 mg (3 separate subcutaneous injections of 225mg each) once every 3 months – quarterly dosing 

DIN

02497859 (single-dose prefilled syringe)

02509474 (single-dose prefilled autoinjector) 

To view the AJOVY™ (fremanezumab) Product Monograph, click here

Strength

0.5 mg and 1 mg tablets

DIN

02284642 (0.5 mg); 02284650 (1.0 mg)

To view the Azilect® Product Monograph, click here

Strength

20 mg/mL and 40 mg/mL

DIN

02245619 (20 mg); 02456915 (40 mg)

To view the Copaxone® Product Monograph, click here

Strength

100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg

DIN

02408007 (100 mcg); 02408015 (200 mcg); 02408023 (400 mcg); 02408031 (600 mcg); 02408058 (800 mcg)

To view the Fentora™ Product Monograph, click here
To view the Fentora™ Guide for Prescribers, click here
To view the Fentora™ Guide for Patients & Caregivers, click here

Strength

1.5 mg NA and 30 µg EE Tablets

DIN

00297143 (21-day pack); 00353027 (28-day pack)

To view the Loestrin® 21-day pack Product Monograph, click here
To view the Loestrin® 28-day pack Product Monograph, click here

Strength

1 mg NA and 20 µg EE Tablets

DIN

00315966 (21-day pack); 00343838  (28-day pack)

To view the Minestrin® 21-day pack Product Monograph, click here
To view the Minestrin® 28-day pack Product Monograph, click here

Strength

0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol per tablet

DIN

02296659

To view the Seasonale® Product Monograph, click here

Strength

0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol and 0.01 mg ethinyl estradiol per tablet

DIN

02346176

To view the Seasonique® Product Monograph, click here

Strength

25 mg/vial and 100 mg/vial

DIN

02392550 (25 mg/vial); 02392569 (100 mg/vial)

To view the Treanda® Product Monograph, click here
To view the Treanda® Guide for Patients & Caregivers, click here

Biosimilar medicines

Uncompromising quality

We know that every one of our products will have an impact on another individual’s health. Our dedication to quality in everything we do is uncompromising, and covers every stage of the development, production, marketing and distribution of our medicines: from the supply of materials to manufacturing and obtaining approval by Health Canada.

We never rest on our laurels, and our passion for excellence drives us to continually improve practices, processes and procedures.